Article Information
History
- December 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ashley N. Barlev1,2,*,
- Susan Malkiel1,*,
- Annemarie L. Dorjée3,
- Jolien Suurmond1,3,#& and
- Betty Diamond1,#&
- 1Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, USA
- 2Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, USA
- 3Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
- ↵&To whom correspondence should be addressed: Betty Diamond, Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030 USA, Tel. +1-516-562-3830, Email: bdiamond{at}northwell.edu or Jolien Suurmond, Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Tel +31-71-562-2317, Email: j.suurmond{at}lumc.nl.
Posted December 04, 2021.
FcγRIIB regulates (auto)antibody responses by limiting marginal zone B cell activation
